d-Conotoxin Tx VIA (reduced) (9CI)(117069-04-2)
- Name: d-Conotoxin Tx VIA (reduced) (9CI)
- Synonyms:158:PN: WO2009075773 FIGURE: 14 unclaimed sequence; 23: PN: CN1982457 FIGURE: 1unclaimed sequence; 3: PN: US20060252917 SEQID: 3 unclaimed sequence; 453: PN:WO2008088422 SEQID: 468 claimed sequence; L-Threonine,L-tryptophyl-L-cysteinyl-L-lysyl-L-glutaminyl-L-serylglycyl-L-a-glutamyl-L-methionyl-L-cysteinyl-L-asparaginyl-L-leucyl-L-leucyl-L-a-aspartyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-cysteinyl-L-a-aspartylglycyl-L-tyrosyl-L-cysteinyl-L-isoleucyl-L-valyl-L-leucyl-L-valyl-L-cysteinyl-;Toxin d-TxVIA; d-Conotoxin Tx VIA (Conus textileclone Tx6.16)
- Molecular Formula:C125H197 N33 O41 S7
- Molecular Weight:
- CAS Registry Number:117069-04-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 40967-67-7/2-Methoxycarbonylsuccinic acid dimethyl ester
- 5348-41-4/ethyl (2E)-2-[2-(1,3-benzodioxol-5-yl)-1-methylethylidene]hydrazinecarboxylate
- 164177-50-8/3H-Carbazole-3,4(9H)-dione,2-methyl-1-(7-methyloctyl)-
- 56681-55-1/2HYDROXY26DIETHYLNMETHOXYMETHYLACETANILIDE
- 6633-98-3/2,5-bis[3-(ethylsulfanyl)propyl]hexanedioic acid
- 132822-60-7/hemoglobin Calais
- 95356-86-8/Thiazolo[2,3-c]-1,2,4-triazol-5(6H)-one, 6-[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]-3-phenyl-
- 160162-48-1/Urea,N-(6-amino-3-pyridinyl)-N'-(1S,2R,4R)-bicyclo[2.2.1]hept-2-yl-
- 20153-49-5/fluorotripentylstannane
- 54878-01-2/METHYL (1R,3S)-2,2-DIMETHYL-3-(2-OXOPROPYL)-CYCLOPROPANEACETATE, 96
- 90388-24-2/1-Hexanamine, 3,5,5-trimethyl-, phosphonomethylated, partially reduced, sodium salts
- 51321-79-0/Sparfosic
- 213920-52-6/2-methyl-4-(2-methylphenyl)diazenyl-benzenediazonium
- 57724-26-2/3-ISOBUTOXY-4-METHOXYBENZALDEHYDE
- 18656-40-1/1,2-DILAUROYL-RAC-GLYCERO-3-PHOSPHOCHOLINE
- 18189-05-4/hexyl anthranilate
- 89808-64-0/Oxazolomycin
- 58918-34-6/(6R,11S)-6,11-dimethyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol hydrobromide (1:1)
- 54578-25-5/Sun Yellow K
- 117069-04-2/d-Conotoxin Tx VIA (reduced) (9CI)
- 101585-37-9/3-[(TOLUENE-4-SULFONYL)-P-TOLYL-AMINO]-PROPIONIC ACID
- 109006-06-6/N-[1-(4-{[(diaminomethylidene)amino]methyl}phenyl)-2-oxo-2-piperidin-1-ylethyl]-4-methylbenzenesulfonamide
- 2783-48-4/Phenylphosphonic acid bis(1-methylpropyl) ester
- 173327-17-8/L-Isoleucinamide,N,N-dimethyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[(1S)-1-(hydroxymethyl)-2-phenylethoxy]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-(9CI)
- 113800-65-0/PYR-VAL-ASN-PHE-SER-THR-GLY-TRP-NH2
- 68920-30-9/Fatty acids, soya, polymers with glycerol, linseed oil, pentaerythritol, phthalic anhydride and soybean oil
- 108734-88-9/ethyl 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)propanoate
- 72412-44-3/N-[(1-ethylpyrrolidin-2-yl)methyl]-4-methoxypyrimidine-5-carboxamide hydrochloride
- 56106-05-9/AKOS BBS-00007770
- 90294-62-5/Chromium, acetylacetone 6-methyl-2,4-heptanedione complexes